Abstract:A small molecule photodiagnostic agent, CY‐1234 nanoparticles (NPs), is reported in this paper. Organic small molecules with near‐infrared‐II (NIR‐II) absorption are successfully designed by increasing the conjugation length and altering the intramolecular charge transfer. Efficient photothermal therapy guided by NIR‐II window photoacoustic imaging is realized by adjusting the aggregation shape of the molecules. Photoacoustic imaging (PAI) and photothermal therapy (PTT) conducted over the near‐infrared‐II (NIR‐II) window offer the benefits of noninvasiveness and deep tissue penetration. This necessitates the development of highly effective therapeutic agents with NIR‐II photoresponsivity. Currently, the predominant organic diagnostic agents used in NIR‐II PAI‐guided PTT are conjugated polymeric materials. However, they exhibit a low in vivo clearance rate and long‐term biotoxicity, limiting their clinical translation. In this study, an organic small molecule (CY‐1234) with NIR‐II absorption and nanoencapsulation (CY‐1234 nanoparticles (NPs)) for PAI‐guided PTT is reported. Extended π‐conjugation is achieved in the molecule by introducing donor–acceptor units at both ends of the molecule. Consequently, CY‐1234 exhibits a maximum absorption peak at 1234 nm in tetrahydrofuran. Nanoaggregates of CY‐1234 are synthesized via F‐127 encapsulation. They exhibit an excellent photothermal conversion efficiency of 76.01% upon NIR‐II light irradiation. After intravenous injection of CY‐1234 NPs into tumor‐bearing mice, strong PA signals and excellent tumor ablation are observed under 1064 nm laser irradiation. This preliminary study can pave the way for the development of small‐molecule organic nanoformulations for future clinical applications.

A carbon nanomaterial derived from a nanoscale covalent organic framework for photothermal therapy in the NIR-II biowindow

Indocyanine Green-Loaded Porphyrin Covalent Organic Frameworks for Photothermal Cancer Therapy

NIR-II-activated biocompatible hollow nanocarbons for cancer photothermal therapy

Metal-Organic Frameworks-Derived Carbon Nanoparticles for Photoacoustic Imaging-Guided Photothermal/Photodynamic Combined Therapy.

Novel small molecule-based organic nanoparticles for second near-infrared photothermal tumor ablation

Quinoid Conjugated Polymer Nanoparticles with NIR-II Absorption Peak Toward Efficient Photothermal Therapy**

A covalent organic framework-based nanoplatform with enhanced photothermal and photodynamic performance for targeted tumor therapy

Extended Pi-Conjugative Carbon Nitride for Single 1064 Nm Laser-Activated Photodynamic/Photothermal Synergistic Therapy and Photoacoustic Imaging

Photothermal therapy of xenografted tumor by carbon nanoparticles-Fe(II) complex

Ultrathin carbon layer coated MoO2 nanoparticles for high-performance near-infrared photothermal cancer therapy

An intelligent NIR-IIb-responsive lanthanide@metal–organic framework core–shell nanocatalyst for combined deep-tumor therapy

NIR-II Light-Assisted Radiotherapy Based on Ultrasmall HfO2-embedded Porous Carbon Nanooctahedra for Overcoming Tumor Radioresistance

NIR absorptive croconic acid/quercetin/CaO2 nanoplatform for tumor calcium overload therapy combined mild photothermal therapy

A Small-Molecule Based Organic Nanoparticle for Photothermal Therapy and Near-Infrared-IIb Imaging

Development of novel nanoporphyrin biomaterials for NIR-II activated photothermal therapy against tumor in vivo

Pt nanozyme-bridged covalent organic framework-aptamer nanoplatform for tumor targeted self-strengthening photocatalytic therapy

NIR-II Responsive Fe-Doped Carbon Nanoparticles for Photothermal-Enhanced Chemodynamic Synergistic Oncotherapy

Extended π-Conjugative Carbon Nitride for Single 1064 nm Laser-Activated Photodynamic/Photothermal Synergistic Therapy and Photoacoustic Imaging

Copolymerized carbon nitride nanoparticles for near-infrared II photoacoustic-guided synergistic photothermal/radiotherapy

Controlled Phase Transition of the Onion-like Carbon Nanostructure for Photothermal Cancer Therapy

Small‐Molecule Phototheranostic Agent with Extended π‐Conjugation for Efficient NIR‐II Photoacoustic‐Imaging‐Guided Photothermal Therapy